Roche received U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus
On Nov. 15, 2022, Roche announced that the U.S. Food and Drug Administration had granted Emergency Use Authorization…
University of Missouri study found Monkeypox mutations caused virus to spread rapidly, evade drugs and vaccines
On Nov. 9, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
Novavax Nuvaxovid COVID-19 Vaccine authorized in the United Kingdom for use as a booster in adults
On Nov. 9, 2022, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Moderna received Health Canada authorization for second Omicron-targeting bivalent booster
On Nov. 4, 2022, Moderna announced that Health Canada had authorized the use of its BA.4/BA.5 Omicron-targeting bivalent…
AIM ImmunoTech received Orphan Drug Designation for Ampligen (rintatolimod) for treatment of Ebola virus disease
On Nov. 2, 2022, AIM ImmunoTech announced that the U.S. Food and Drug Administration had granted Orphan Drug…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Nanotechnology | Therapeutics | Vaccine
COVID-causing virus in air detected with high-tech bubbles
On Oct. 25, 2022, Pacific Northwest National Laboratory (PNNL) announced that scientists have shown that they can detect…
Biotechnology | HIV | NIH | Vaccine
Three-dose hepatitis B vaccine regimen protected people with HIV
On Oct. 20, 2022, the National Institutes of Health announced that a three-dose course of the hepatitis B…
EMA’s CHMP for Human Use issued positive opinion recommending authorization for use of Spikevax in children 6 months – 5 years in EU
On Oct. 19, 2022, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
Moderna received Authorization for Emergency Use from FDA of Omicron-targeting bivalent COVID-19 booster vaccine for children
On Oct. 12, 2022, Moderna announced that it had received emergency use authorization from the U.S. Food and…
Intranasal COVID-19 vaccine candidateﾒs clinical data highlighted need for further development of nasal spray vaccines
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
Novavax and SK bioscience filed post approval change application in South Korea for Nuvaxovid COVID-19 vaccine as booster in adults
On Oct. 10, 2022, Novavax announced that partner, SK bioscience, had submitted a Post Approval Change Application to…
Switzerland’s Federal Office of Public Health recommended Novavax Nuvaxovid COVID-19 vaccine as booster in adults
On Oct. 10, 2022, Novavax announced that Switzerland’s Federal Office of Public Health had recommended Nuvaxovid (NVX-CoV2373) as…
FDA authorized Monkeypox test
On Oct. 7, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorizationto Abbott Molecular, Inc.,…
Washington University in St. Louis COVID-19 nasal vaccine technology licensed to Ocugen
On Oct. 4, 2022, Washington University in St. Louis announced it had licensed the rights to develop, manufacture…
USDA opened new poultry research facility in Georgia
On Oct. 4, 2022, the United States Department of Agriculture’s (USDA) Agricultural Research Service (ARS), Southeast Poultry Research…
Uganda declared Ebola virus disease outbreak
On Sept. 20, 2022, The health authorities in Uganda declared an outbreak of Ebola after a case of…
Novavax Nuvaxovid COVID-19 vaccine received expanded EUA in Taiwan for use in adolescents aged 12 through 17
On Sept. 16, 2022, Novavax announced that the Taiwan Food and Drug Administration had granted expanded emergency use…
Novavax Nuvaxovid COVID-19 vaccine became available in Israel for individuals aged 12 and older
On Sept. 16, 2022, Novavax announced that the Israel Ministry of Health had granted an import and use…
Novavax and Serum Institute of India announced full product registration in South Africa of Novavax COVID-19 vaccine
On Sept. 13, 2022, Novavax and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced…
FDA authorized Quest Diagnostics’ proprietary Monkeypox test for emergency use
On Sept. 7, 2022, Quest Diagnostics announced that it had received emergency use authorization (EUA) from the U.S….
Swissmedic authorized Novavax Nuvaxovid COVID-19 vaccine for adolescents aged 12 through 17 and as booster in adults
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…
Democratic Republic of the Congo declared Ebola resurgence in North Kivu
On Aug. 23, 2022, Health authorities in the Democratic Republic of the Congo declared a resurgence of Ebola…
U.S. FDA granted EUA for Novavax COVID-19 vaccine, adjuvanted for adolescents Aged 12 through 17
On Aug. 19, 2022, Novavax announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) had received expanded emergency use…
WHO experts gave Monkeypox virus variants new names
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
Novavax Nuvaxovid COVID-19 vaccine approved in South Korea for use in adolescents aged 12 through 17
On Aug. 12, 2022, Novavax announced that partner, SK bioscience, had received a Post Approval Change Application approval…
HHS announced Monkeypox (mpox) Emergency Use Authorizations for medical devices
On Aug. 9, 2022, the the Department of Health and Human Services (HHS) announced it had determined that…
U.S. Department of Health and Human Services declared Monkeypox (Mpox) a public health emergency
On Aug. 4, 2022, the U.S. Department of Health and Human Services declared the ongoing spread of monkeypox…
Patient with HIV achieved remission following stem cell transplant
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
BD, CerTest Biotec announced commercial launch of Monkeypox test
On Jul. 27, 2022, BD (Becton, Dickinson) announced their newly developed molecular polymerase chain reaction (PCR) test for…
Novavax Nuvaxovid COVID-19 vaccine granted provisional registration in Australia for use in adolescents aged 12 through 17
On Jul. 26, 2022, Novavax announced that the Australian Therapeutic Goods Agency had granted expanded approval for provisional…